SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001493152-21-012568
Filing Date
2021-05-21
Accepted
2021-05-21 17:30:22
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2487682
2 filename2.htm EX-10.3 163464
3 filename3.htm EX-10.10 19230
4 filename4.htm EX-10.11 252676
5 filename5.htm EX-10.12 20418
6 filename6.htm EX-10.13 153963
7 filename7.htm EX-10.14 19819
8 filename8.htm EX-21.1 2829
9 formdrsa_001.jpg GRAPHIC 3249
10 formdrsa_002.jpg GRAPHIC 24784
11 formdrsa_003.jpg GRAPHIC 15885
12 formdrsa_005.jpg GRAPHIC 14873
13 formdrsa_007.jpg GRAPHIC 11119
14 image_001.jpg GRAPHIC 11906
15 ex10-11_001.jpg GRAPHIC 4607
16 ex10-3_001.jpg GRAPHIC 3237
  Complete submission text file 0001493152-21-012568.txt   3245452
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: DRS/A | Act: 33 | File No.: 377-04475 | Film No.: 21950334
SIC: 2836 Biological Products, (No Diagnostic Substances)